| AS | Atherosclerosis |
| D-flow | Disturbed flow |
| ECs | Endothelial cells |
| ICAM-1 | Intercellular adhesion molecule-1 |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| vWF | Von Willebrand factor |
| GPIbα | Glycoprotein (GP) Ibα |
| GPVI | Glycoprotein VI |
| αIIbβ3 | Integrin αIIbβ3 |
| FLIPRs | Flow-induced protrusions |
| PMPs | Platelet microparticles |
| PECAM-1 | Platelet endothelial cell adhesion molecule-1 |
| MACE | Major cardiovascular adverse event |
| LDL | Low-density lipoprotein |
| HDL | High-density lipoprotein |
| LRP | LDL receptor-related protein |
| FAK | Focal adhesion kinase |
| oxLDL | Oxidized low-density lipoprotein |
| VSMCs | Vascular smooth muscle cells |
| SMCs | Smooth muscle cells |
| LOX-1 | Lectin-like oxidized LDL receptor 1 |
| DM | Diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| PGI2 | Prostacyclin |
| glycLDL | Glycosylated LDL |
| MPV | Mean platelet volume |
| sGPVI | Soluble dimeric GPVI |
| CAD | Coronary atherosclerotic heart disease |
| CEU | Contrast-enhanced ultrasound |
| PSGL-1 | P-selectin glycoprotein ligand 1 |
| DCs | Dendritic cells |
| PARs | Protease-activated receptors |
| IL-1β | Interleukin (IL)-1β |
| TRAF | TNF receptor-related factor |
| PF-4 | Platelet factor 4 |
| NETs | Neutrophil extracellular traps |
| PBP | Platelet basic protein |
| CTAP-III | Connective tissue-activating peptide III |
| β-TG | β thrombin |
| NAP-2 | Neutrophil-activating peptide 2 |
| SDF-1 | Stromal cell-derived factor-1 |
| PDGF | Platelet-derived growth factor |
| PDGFR | Platelet-derived growth factor receptors |
| CyPA | Cyclophilin A |
| HMG1 | Amphoterin |